Fed. Circ. Affirms Warner Chilcott Atelvia Patents Are Invalid
The Federal Circuit on Friday agreed with a New Jersey district court that claims in two of Warner Chilcott Co. LLC's patents covering its osteoporosis drug Atelvia are obvious and therefore...To view the full article, register now.
Already a subscriber? Click here to view full article